Literature DB >> 11936928

Barriers to osteoporosis identification and treatment among primary care physicians and orthopedic surgeons.

Christine Simonelli1, Kathleen Killeen, Susan Mehle, Leah Swanson.   

Abstract

OBJECTIVE: To understand better the barriers among orthopedic surgeons and primary care physicians in identifying and treating possible osteoporosis in patients hospitalized with a fragility fracture sustained spontaneously or from a fall no greater than standing height.
METHODS: A 1-page, 7-question survey was sent to 35 admitting orthopedic surgeons and 75 primary care physicians at a midwestern managed care organization in March 2001. Returned surveys were collected until 30 days had passed since the mailing. Primary care physicians were board-certified family practitioners and internal medicine physicians. All orthopedists were admitting surgeons in the hospital system. Responders were anonymous, and posted surveys were returned to the Orthopaedic Collaborative Practice office. The surveys were color-coded to separate responses from orthopedic surgeons and primary care physicians.
RESULTS: Thirty-one surveys were returned: 23 (31%) from primary care physicians and 8 (23%) from orthopedic surgeons. Survey respondents agreed that the responsibility for postfracture attention to nutritional needs, including calcium and vitamin D, rested with the primary care provider. When asked about barriers to recommending bone mineral density testing with dual energy x-ray absorptiometry, 9 primary care physicians (39%) thought this type of testing was unnecessary for treatment, and 4 primary care physicians (17%) thought a barrier was caused by patient frailty. Primary care physicians indicated that potential adverse effects of medication (n=14 [61%]) and cost of therapy (n=13 [57%]) were the main factors limiting treatment. When asked to identify the single most important barrier in treatment, 14 physicians (61%) indicated cost was the greatest deterrent. Twenty-one primary care physicians (91%) reported they would be more likely to treat a patient with osteoporosis if a safe medication with proven fracture risk reduction were available. Primary care physicians indicated they were more likely to treat independently living adults (n=12 [52%]) and women compared with men (n=15 [65%]). All orthopedic surgeons (n=8) were willing for all patients to be evaluated in consultation with a nurse practitioner. Primary care respondents were less apt to agree with a nurse practitioner referral (n=5 [22%]). Both primary care physicians (n=16 [70%]) and orthopedic surgeons (n=4 [50%]) agreed that there is a need for increased primary care education about managing osteoporosis in patients hospitalized with low-impact fracture.
CONCLUSIONS: Orthopedic surgeons were consistent in their opinion that postfracture attention to osteoporosis should rest with the primary care physician. Primary care physicians agree but report that cost and possible adverse effects of medication are major barriers to this care. Despite therapies for high-risk postfracture patients showing relative safety and proven efficacy in reducing future fractures, deterrents to this care are focused on cost and potential adverse effects. Further education is needed to promote a standard of care for the postfracture patient that is directed toward the prevention of a subsequent fracture.

Entities:  

Mesh:

Year:  2002        PMID: 11936928     DOI: 10.4065/77.4.334

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  60 in total

1.  Testing and treatment for osteoporosis following hip fracture in an integrated U.S. healthcare delivery system.

Authors:  A Shibli-Rahhal; M S Vaughan-Sarrazin; K Richardson; P Cram
Journal:  Osteoporos Int       Date:  2011-01-27       Impact factor: 4.507

2.  Management of osteoporosis in general practice: a cross-sectional survey of primary care practitioners in Spain.

Authors:  L Pérez-Edo; M Ciria Recasens; C Castelo-Branco; P Orozco López; A Gimeno Marqués; C Pérez; J Manasanch Dalmau
Journal:  Osteoporos Int       Date:  2004-01-27       Impact factor: 4.507

3.  Knowledge of orthopaedic surgeons in managing patients with fragility fracture.

Authors:  Reza Sorbi; Mohamad Reza Aghamirsalim
Journal:  Int Orthop       Date:  2012-01-27       Impact factor: 3.075

4.  Predictors of treatment with osteoporosis medications after recent fragility fractures in a multinational cohort of postmenopausal women.

Authors:  Susan L Greenspan; Allison Wyman; Frederick H Hooven; Silvano Adami; Stephen Gehlbach; Frederick A Anderson; Steven Boone; Andrea Z Lacroix; Robert Lindsay; J Coen Netelenbos; Johannes Pfeilschifter; Stuart Silverman; Ethel S Siris; Nelson B Watts
Journal:  J Am Geriatr Soc       Date:  2012-02-08       Impact factor: 5.562

5.  Canadian orthopedic surgeons and postfracture osteoporosis care: moving from persuasion toward facilitation.

Authors:  Earl R Bogoch
Journal:  Can J Surg       Date:  2008-02       Impact factor: 2.089

6.  Physiatrists' opinions and practice patterns for bone health after SCI.

Authors:  M C Ashe; J J Eng; A Krassioukov
Journal:  Spinal Cord       Date:  2008-08-19       Impact factor: 2.772

7.  Correlation between patient recall of bone densitometry results and subsequent treatment adherence.

Authors:  Cynthia S Pickney; Jon A Arnason
Journal:  Osteoporos Int       Date:  2005-03-03       Impact factor: 4.507

8.  Osteoporosis practice patterns in 2006 among primary care physicians participating in the NORA study.

Authors:  T W Weiss; E S Siris; E Barrett-Connor; P D Miller; C A McHorney
Journal:  Osteoporos Int       Date:  2007-06-19       Impact factor: 4.507

9.  Evaluation and management of osteoporosis following hospitalization for low-impact fracture.

Authors:  Christine Simonelli; Ya-Ting Chen; Julie Morancey; Anne F Lewis; Thomas A Abbott
Journal:  J Gen Intern Med       Date:  2003-01       Impact factor: 5.128

Review 10.  Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review.

Authors:  V Elliot-Gibson; E R Bogoch; S A Jamal; D E Beaton
Journal:  Osteoporos Int       Date:  2004-07-16       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.